Jiang QP, Liu SY, Yang YX, Tan XX, Peng J, Xiong ZT, Li Z: CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature. Diag Pathol 2012, 7:133.Jiang Qp, Liu Sy, Yang YX, et al. CD20-positive NK/T-cell lym- phoma with indolent ...
Lymphoid clusters (LC) containing CD20-positive B cells in kidney allografts undergoing acute cellular rejection (ACR) have been identified in small studies as a prognostic factor for glucocorticoid resistance and graft loss. Allograft biopsies obtained during the first episode of ACR in 120 recipients...
The presence of T cells that are dimly positive for the B cell marker CD20 is well-established in autoimmunity and correlates with disease severity in various diseases. Further, we previously identified that the level of CD20-positive T cells was three–fourfold elevated in ascites fluid of ovari...
CD20 positive peripheral T cell lymphoma unspecified: a case report淋巴瘤,非霍奇金抗原,CD20病例报告[文献类型]患者男,81岁.左足背复发性溃疡8年,渐累及双下肢.各系统检查未见异常.皮肤科检查: 左足背红肿,约7 cm×10 cm范围的皮肤溃疡面,基底部可见肌腱,皮损周围皮肤呈紫褐色,边缘堤状隆起;右足内缘可见...
Utilization of antibodies to deliver highly potent cytotoxic agents to corresponding antigen-overexpressed tumor cells is a clinically validated therapeutic strategy. Ofatumumab (OFA, trade name Arzerra) is a fully human CD20-specific antibody that is active against CD20-positive B-cell lymphoma/chronic ...
Schweizer A, Wohner M, Prescher H, Brossmer R, Nitschke L: Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues. Eur J Immunol. 2012, 2012: 2012-http://www.ncbi.nlm.nih.gov/pubmed/22777817, Google Scholar Kantarjian H, Thomas D, Jorgensen J,...
Namalwa,whichwereCD20positive,usingDimethylSulfoxidetodetectthegrowthrateamongdifferentRituximabconcentration groups(12.5,25,50umol/L)anddifferenttimegroups(12,24,48,72h),inordertochooseproperdrugconcentration andactiontime.Accordingtoaboveresult,establishcontrolandexperimentalgroup(50umol/Lfor48h).Apoptosisratesof...
Schweizer A, Wohner M, Prescher H, Brossmer R, Nitschke L: Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues. Eur J Immunol. 2012, 2012: 2012-http://www.ncbi.nlm.nih.gov/pubmed/22777817, Google Scholar Kantarjian H, Thomas D, Jorgensen J,...
Triple staining with anti‐TCRαβ (blue) and anti‐MHC II (red) revealed that TORID‐positive cells (green) predominantly localized in the red pulp, and to a lesser extent, in the periarteriolar lymphoid sheath (PALS), in the marginal zones, and B‐cell follicles in particular (Figure ...
31.Withoff,S.et al.Characterization of BIS20x3,a bi-specific antibodyactivating and retargeting T-cells to CD20-positive B-cells.Br.J.Cancer 84,1115-1121(2001). 32.Goldenberg,D.M.et al.Properties and structure-functionrelationships of veltuzumab (hA20),a humanized anti-CD20 monoclonalantibod...